These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 6363545)

  • 1. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth cycle-dependent generation of complement-resistant Leishmania promastigotes.
    Franke ED; McGreevy PB; Katz SP; Sacks DL
    J Immunol; 1985 Apr; 134(4):2713-8. PubMed ID: 3973390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing of Leishmania tropica amastigotes by factors in normal human serum.
    Hoover DL; Berger M; Nacy CA; Hockmeyer WT; Meltzer MS
    J Immunol; 1984 Feb; 132(2):893-7. PubMed ID: 6690622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes.
    Mosser DM; Edelson PJ
    J Immunol; 1985 Oct; 135(4):2785-9. PubMed ID: 3161950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.
    Wozencraft AO; Blackwell JM
    Immunology; 1987 Apr; 60(4):559-63. PubMed ID: 2953670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3.
    Mosser DM; Wedgwood JF; Edelson PJ
    J Immunol; 1985 Jun; 134(6):4128-31. PubMed ID: 3886796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania species: mechanisms of complement activation by five strains of promastigotes.
    Mosser DM; Burke SK; Coutavas EE; Wedgwood JF; Edelson PJ
    Exp Parasitol; 1986 Dec; 62(3):394-404. PubMed ID: 3780933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major.
    Mosser DM; Edelson PJ
    Nature; 1987 May 28-Jun 3; 327(6120):329-31. PubMed ID: 3035377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the macrophage in cutaneous leishmaniasis.
    Farah FS; Samra SA; Nuwayri-Salti N
    Immunology; 1975 Oct; 29(4):755-64. PubMed ID: 1184120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.
    Daha MR; Van Es LA
    Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
    Ambrosio AR; De Messias-Reason IJ
    Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. II. Selective destruction of different Leishmania species in activated guinea-pig and mouse macrophages.
    Behin R; Mauel J; Biroum-Noerjasin ; Rowe DS
    Clin Exp Immunol; 1975 May; 20(2):351-8. PubMed ID: 765014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
    Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
    J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S; Lint TF
    J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
    Liang-Takasaki CJ; Grossman N; Leive L
    J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum.
    Puentes SM; Dwyer DM; Bates PA; Joiner KA
    J Immunol; 1989 Dec; 143(11):3743-9. PubMed ID: 2584716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.